TY - JOUR
KW - Adult
KW - Anxiety/diagnosis/drug therapy/psychology
KW - Buprenorphine/administration & dosage
KW - Counseling/methods/trends
KW - Depression/diagnosis/drug therapy/psychology
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Male
KW - Narcotic Antagonists/administration & dosage
KW - Opiate Substitution Treatment/methods/psychology/trends
KW - Opioid-Related Disorders/diagnosis/drug therapy/psychology
KW - Young Adult
AU - J. M. Streck
AU - T. A. Ochalek
AU - G. J. Badger
AU - S. C. Sigmon
A1 - 
BT - Experimental and clinical psychopharmacology
C5 - Measures; Opioids & Substance Use
CP - 4
CY - United States
DO - 10.1037/pha0000199
IS - 4
JF - Experimental and clinical psychopharmacology
PB - APA, all rights reserved)
PP - United States
PY - 2018
SN - 1936-2293; 1064-1297
SP - 403
EP - 409
EP - 
T1 - Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms
T2 - Experimental and clinical psychopharmacology
TI - Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms
U1 - Measures; Opioids & Substance Use
U2 - 29939049
U3 - 10.1037/pha0000199
VL - 26
VO - 1936-2293; 1064-1297
Y1 - 2018
ER -